Patient Pathfinder: Clinical Trials
Clinical Trials for Myeloproliferative Neoplasms
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myeloproliferative Neoplasms (MPNs), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 127 active Myeloproliferative Neoplasms trials
Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
A Study to Evaluate INCA033989 Administered in Participants With Myeloproliferative Neoplasms
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
TGRX-678 US Phase I for Subjects With Refractory or Advanced Chronic Myelogenous Leukemia
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
There are 127 active Myeloproliferative Neoplasms trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.